Memantine Hydrochloride 14 mg/1

Memantine Hydrochloride 14 mg/1 is an extended-release capsule used to manage moderate to severe Alzheimer's disease symptoms. This medication helps regulate glutamate activity in the brain, potentially improving cognitive function and daily living activities.

Memantine Hydrochloride 14 mg/1 is primarily used to treat moderate to severe Alzheimer's disease. It works by modulating glutamate activity, which may help improve cognitive function, memory, and the ability to perform daily activities. This medication is often used as part of a comprehensive treatment plan for Alzheimer's disease.

Common effects of Memantine Hydrochloride 14 mg/1 may include dizziness, headache, and constipation. Some individuals might experience confusion, fatigue, or an increase in blood pressure. These effects can vary from person to person and may not affect everyone who takes the medication.

Memantine Hydrochloride 14 mg/1 should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should be stored at room temperature and kept out of reach of children. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Memantine Hydrochloride 14 mg/1 may interact with other medications, including certain anticholinergics, dopamine antagonists, and medications that affect the central nervous system. It is important to discuss all current medications with a healthcare provider to minimize the risk of interactions. Additionally, alcohol consumption should be avoided while taking this medication.